Overview

The Efficacy of Xuebijing Injection on Sepsis

Status:
Completed
Trial end date:
2020-01-08
Target enrollment:
Participant gender:
Summary
The Efficacy of Xuebijing Injection in Adult Patients with Sepsis
Phase:
Phase 4
Details
Lead Sponsor:
Southeast University, China
Collaborators:
National Health and Family Planning Commission, P.R.China
Tianjin Chasesun Pharmaceutical Co., LTD